Related content

Response to ‘Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives’

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 604-604

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extended and continuous use of hormonal contraceptives to reduce menstruation

By Wiegratz Inka   Kissler Stefan   Kuhl Herbert   Kaufmann Manfred  

Women's Health, Vol. 2, Iss. 5, 2006-09 ,pp. : 705-716

Future Medicine

Access to resources Recommend Favorite

Equivalent Dynamic Human Brain NK1‐Receptor Occupancy Following Single‐Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 243-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drugs for healthy people: The culture of testing hormonal contraceptives for women and men

By Oudshoorn Nelly  

Clio Medica/The Wellcome Series in the History of Medicine, Vol. 66, Iss. 1, 2002-04 ,pp. : 123-140

Rodopi

Access to resources Recommend Favorite

P086: Effectiveness of interventions to decrease imaging among emergency department low back pain presentations: a systematic review

By  

Canadian Journal of Emergency Medicine, Vol. 19, Iss. S1, 2017-05 ,pp. : S107-S107

Cambridge University Press

Access to resources Recommend Favorite